Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p

Suzanne Faure-Dupuy1,2, Tobias Riedl1,3, Maude Rolland4

  • 1Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Insights

Immune-mediated APOBEC3B induction, regulated by NF-κB and miR-138-5p, effectively reduces hepatitis B virus cccDNA. Inhibiting miR-138-5p may enhance this antiviral effect for new HBV therapies.

Area of Science:

  • Hepatology and Virology
  • Immunology
  • Molecular Biology

Background:

  • Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) persistence is a major barrier to chronic infection cure.
  • Immune-mediated induction of cytidine deaminase APOBEC3B (A3B) has shown potential in reducing HBV cccDNA.
  • Understanding the regulatory mechanisms of A3B induction is crucial for developing effective antiviral strategies.

Purpose of the Study:

  • To elucidate the signaling pathways and regulatory mechanisms governing A3B induction.
  • To investigate the role of NF-κB and microRNA-138-5p (miR-138-5p) in A3B-mediated HBV control.
  • To evaluate the therapeutic potential of modulating A3B expression for HBV treatment.

Main Methods:

  • Utilized differentiated HepaRG cells and primary human hepatocytes with or without HBV infection.
  • Employed knockdown of NF-κB signaling components, siRNA/miRNA transfections, and treatment with lymphotoxin beta receptor (LTβR)-agonist (BS1).
  • Applied a comprehensive suite of molecular analyses including qPCR, immunoblotting, sequencing, and mass spectrometry.

Main Results:

  • Both canonical and non-canonical NF-κB pathways are essential for A3B induction and anti-HBV activity.
  • A3B expression is post-transcriptionally regulated by miR-138-5p, which promotes A3B mRNA decay; its overexpression reduced A3B levels and antiviral effects.
  • LTβR-agonist treatment significantly reduced cccDNA by 80% without damaging key host genes, independent of cccDNA transcriptional activity.

Conclusions:

  • APOBEC3B is the first described enzyme capable of degrading both transcriptionally active and inactive HBV cccDNA.
  • Inhibiting miR-138-5p should be considered in combination therapies for HBV, particularly when leveraging immune-mediated A3B induction.
  • A3B-mediated cccDNA decay presents a promising therapeutic avenue for chronic HBV infection.
Abstract

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.7K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.6K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K